Sales Subject to Royalties. Sales of Collaboration Product between AstraZeneca, its Affiliates and Sublicencees that are purchased for re-sale shall not be subject to royalties hereunder. Royalties shall be calculated on AstraZeneca’s and its Affiliates’ sale of the Collaboration Products to Third Parties (including distributors). Royalties shall be payable only once per unit of Collaboration Product.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Hutchison China MediTech LTD), License and Collaboration Agreement (Hutchison China MediTech LTD)
Sales Subject to Royalties. Sales of Collaboration Product between AstraZeneca, its Affiliates and Sublicencees that are purchased for re-sale shall not be subject to royalties hereunder. Royalties shall be calculated on AstraZeneca’s and its Affiliates’ sale of the [**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Collaboration Products to Third Parties (including distributors). Royalties shall be payable only once per unit of Collaboration Product.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Hutchison China MediTech LTD), License and Collaboration Agreement (Hutchison China MediTech LTD)
Sales Subject to Royalties. Sales of Collaboration Product between AstraZeneca, its Affiliates and Sublicencees that are purchased for re-sale shall not be subject to royalties hereunder. Royalties shall be calculated on AstraZeneca’s and its Affiliates’ sale of the Collaboration Products to Third Parties (including distributors). Royalties shall be payable only once per unit of Collaboration Product..
Appears in 1 contract
Samples: License and Collaboration Agreement (Hutchison China MediTech LTD)
